During Phase 2, we will conduct a pilot study to evaluate the acceptability, feasibility, and utility and construct validity of the ACASI-SHQ. Individuals consenting to the host study will be offered the opportunity to participate in the pilot study, and they will receive a manualized written informed consent procedure. We will enroll a total of 80 individuals into the pilot study. All participants will complete two measures of social harm at monthly research appointments for a three month period. The social harms assessments will be (1) the ACASI-SHQ that was developed in Phase 1 and (2) the HIV Vaccine Trials Network (HVTN) Social Impact Assessment. At each appointment, the order in which the instruments are delivered will be counterbalanced to control for carryover effects. At the end of Phase 2, host study research team will complete the ACASI-SHQ Feasibility and Acceptability Questionnaire. Additionally, the PI and Co-I will conduct a focus group with the research team to collect qualitative data on the feasibility, acceptability, and perceived benefits of the ACASI-SHQ and information to guide its future implementation.